# A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Study · id `cardio:ct-nct07527299` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07527299](<https://clinicaltrials.gov/study/NCT07527299>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07527299

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1070 participants.

## Technical summary

Registry record NCT07527299. Randomized; single masking; primary purpose treatment. Start 2026-08-26 (actual); primary completion 2028-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1070 participants (planned count; ClinicalTrials.gov record NCT07527299, source copy `cardio:ctgov-nct07527299-2026-11-03`, retrieved 2026-11-18)
- Started: 2026-08-26 (actual) (ClinicalTrials.gov record NCT07527299, source copy `cardio:ctgov-nct07527299-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2028-11-30 (anticipated) (ClinicalTrials.gov record NCT07527299, source copy `cardio:ctgov-nct07527299-2026-11-03`, retrieved 2026-11-18)
- Completion: 2031-08-24 (anticipated) (ClinicalTrials.gov record NCT07527299, source copy `cardio:ctgov-nct07527299-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07527299, source copy `cardio:ctgov-nct07527299-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07527299-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Acronym: SPAA PFA
- Condition: Atrial Fibrillation
- Intervention (Device): VARIPULSE Catheter System
- Intervention (Device): LAAO Device
- Lead sponsor: Biosense Webster, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

## Provenance

Content hash: 8a4572cfae5be74bc1346ff5c256f228d1de846f813ca30e404c3ee51a32a288
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
